Spyre Therapeutics, Inc.

By person

17 insiders · 147 transactions

74.2×

Cameron Turtle holds 74.2 times base salary in stock. $49.37M of shares against $665.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Cameron Turtle last reported holding, valued at $89.35, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fairmount Funds Management LLC entity

Director

—

$399.66M (1) scheduled

−$399.66M

0.0000%

$0.00

—

Turtle Cameron

Chief Executive Officer

—

$9.99M (34) scheduled

−$9.99M

552,540

0.6266%

$49.37M

+2,231%

HENDERSON MICHAEL THOMAS

Director

—

$7.95M (5) scheduled

−$7.95M

68,606

0.0778%

$6.13M

—

Burrows Scott L

Chief Financial Officer

—

$7.68M (22) scheduled

−$7.68M

79,762

0.0905%

$7.13M

—

Sloan Sheldon

Chief Medical Officer

—

$7.35M (11) scheduled

−$7.35M

0.0000%

$0.00

—

Albers Jeffrey W.

Director

—

$2.66M (5) scheduled

−$2.66M

9,360

0.0106%

$836.32K

−72.8%

King-Jones Heidy

See Remarks

—

$2.48M (5) scheduled

−$2.48M

2,845

0.0032%

$254.20K

0.0%

Quinn Anthony G.

President & CEO

$2.10M (25)

—

+$2.10M

550,540

0.6244%

$49.19M

—

Novartis Bioventures Ltd entity

10% owner

—

$1.37M (5)

−$1.37M

2,175,314

2.47%

$194.36M

−5.9%

Alspaugh Jonathan

President and CFO

$604.66K (5)

—

+$604.66K

165,372

0.1876%

$14.78M

—

ORBIMED ADVISORS LLC entity

10% owner

$563.88K (3)

—

+$563.88K

1,469,524

1.67%

$131.30M

+8.0%

Shanafelt Armen

Director

$549.69K (3)

—

+$549.69K

150,000

0.1701%

$13.40M

—

York Charles N II

Chief Financial Officer and VP

$108.25K (5)

—

+$108.25K

34,787

0.0395%

$3.11M

+221.3%

Schuchart Aaron

Chief Business Officer

—

$57.01K (2)

−$57.01K

2,500

0.0028%

$223.38K

—

Souza Marcio

Director

$50.47K (1)

—

+$50.47K

90,000

0.1021%

$8.04M

—

Hanley Jr. Michael Conick

Chief Business Officer

$20.02K (1)

—

+$20.02K

36,200

0.0411%

$3.23M

+352.5%

GEORGIOU GEORGE

Director

—

175,861

0.1994%

$15.71M

+26.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Quinn Anthony G.

4 Oct 2019

President & CEO

Exercised, kept

17,603

$6.31

$111.07K

Quinn Anthony G.

4 Oct 2019

President & CEO

Exercised, kept

662

$5.46

$3.61K

Quinn Anthony G.

6 Feb 2019

President & CEO

Exercised, kept

7,433

$6.31

$46.90K

Quinn Anthony G.

6 Feb 2019

President & CEO

Exercised, kept

1,323

$5.46

$7.22K

Quinn Anthony G.

7 Dec 2018

President & CEO

Exercised, kept

18,584

$6.31

$117.27K

Quinn Anthony G.

7 Dec 2018

President & CEO

Exercised, kept

3,306

$5.46

$18.05K

Quinn Anthony G.

7 Dec 2018

President & CEO

Exercised, kept

150,000

$4.11

$616.50K

Schuchart Aaron

17 Aug 2018

Chief Business Officer

Exercised, kept

8,500

$3.50

$29.75K

GEORGIOU GEORGE

13 Aug 2018

Director

Exercised, kept

20,000

$4.73

$94.60K

GEORGIOU GEORGE

13 Aug 2018

Director

Exercised, kept

17,333

$7.28

$126.18K

Quinn Anthony G.

12 Jul 2018

Interim CEO

Exercised, kept

14,866

$6.31

$93.80K

Quinn Anthony G.

12 Jul 2018

Interim CEO

Exercised, kept

24,000

$7.04

$168.96K

Quinn Anthony G.

11 Jul 2018

Interim CEO

Exercised, kept

3,307

$5.46

$18.06K

Quinn Anthony G.

15 Feb 2018

Interim CEO

Exercised, kept

15,211

$5.46

$83.05K

Show all 147 transactions →

Spyre Therapeutics, Inc.

By person

Individual transactions

What was left out